Overview
Immunoglobulin A vasculitis (IgA vasculitis), formerly known as Henoch-Schönlein purpura (HSP), is the most common systemic vasculitis of childhood. It is characterized by inflammation of small blood vessels (small-vessel vasculitis) with deposition of IgA-containing immune complexes in affected tissues. The disease primarily affects the skin, gastrointestinal tract, joints, and kidneys. The hallmark clinical feature is palpable purpura — a raised, non-blanching rash typically distributed over the lower extremities and buttocks. Other key manifestations include abdominal pain (often colicky, sometimes accompanied by gastrointestinal bleeding), arthritis or arthralgia (particularly affecting the knees and ankles), and renal involvement ranging from mild hematuria and proteinuria to, in a minority of cases, progressive glomerulonephritis that can lead to chronic kidney disease. IgA vasculitis frequently follows an upper respiratory tract infection, and various infectious agents, medications, and environmental triggers have been implicated. The condition predominantly affects children between the ages of 3 and 10 years, though it can occur at any age. Adults tend to have more severe disease, particularly with regard to renal complications. The disease is generally self-limiting in children, with most cases resolving within weeks to months. Treatment is primarily supportive, including adequate hydration, rest, and nonsteroidal anti-inflammatory drugs (NSAIDs) for joint pain. Corticosteroids may be used for severe gastrointestinal symptoms or significant renal involvement. In cases of progressive nephritis, immunosuppressive agents such as cyclophosphamide, azathioprine, or mycophenolate mofetil may be considered. Long-term follow-up is recommended to monitor for renal complications, which represent the most important determinant of long-term prognosis.
Also known as:
Clinical phenotype terms— hover any for plain English:
Multifactorial
Caused by a mix of several genes and environmental factors
Childhood
Begins in childhood, roughly ages 1 to 12
FDA & Trial Timeline
5 eventsThe Children's Hospital of Zhejiang University School of Medicine
Capital Institute of Pediatrics, China — PHASE4
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University — NA
Hopital Foch — PHASE3
Children's Hospital of Fudan University — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Immunoglobulin A vasculitis.
4 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Immunoglobulin A vasculitis.
Community
No community posts yet. Be the first to share your experience with Immunoglobulin A vasculitis.
Start the conversation →Latest news about Immunoglobulin A vasculitis
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Immunoglobulin A vasculitis
What is Immunoglobulin A vasculitis?
Immunoglobulin A vasculitis (IgA vasculitis), formerly known as Henoch-Schönlein purpura (HSP), is the most common systemic vasculitis of childhood. It is characterized by inflammation of small blood vessels (small-vessel vasculitis) with deposition of IgA-containing immune complexes in affected tissues. The disease primarily affects the skin, gastrointestinal tract, joints, and kidneys. The hallmark clinical feature is palpable purpura — a raised, non-blanching rash typically distributed over the lower extremities and buttocks. Other key manifestations include abdominal pain (often colicky, s
How is Immunoglobulin A vasculitis inherited?
Immunoglobulin A vasculitis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Immunoglobulin A vasculitis typically begin?
Typical onset of Immunoglobulin A vasculitis is childhood. Age of onset can vary across affected individuals.
Are there clinical trials for Immunoglobulin A vasculitis?
Yes — 4 recruiting clinical trials are currently listed for Immunoglobulin A vasculitis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Immunoglobulin A vasculitis?
17 specialists and care centers treating Immunoglobulin A vasculitis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.